UPDATE : Saturday, March 24, 2018
Gilead, Yuhan to jointly promote hepatitis C drugs
Gilead Sciences Korea and Yuhan Corporation said Thursday the two companies...
by Marian Chu  |  2017-08-31 17:08
Abbvie gets approval for phase 3 clinical trials to treat Crohn’s disease
Abbvie’s new drug Risankizumab, being developed to treat the Crohn’s diseas...
by Lee Hye-seon  |  2017-08-31 15:49
Huons to export botulinum toxin worth W100 bil.
Huons said Thursday it has agreed with major companies from Europe, Russia ...
by Constance Williams  |  2017-08-31 15:23
Hanmi to manage JVM’s overseas business
Hanmi Pharmaceuticals said Thursday that it will directly manage the overse...
by Lee Han-soo  |  2017-08-31 13:51
Opdivo proves competence among local immunotherapies
Ono Pharma Korea and Bristol-Myers Squibb (BMS) Korea said Thursday its blo...
by Marian Chu  |  2017-08-31 13:47
Novartis gains historic FDA approval for CAR-T leukemia therapy
The U.S. Food and Drug Administration Wednesday approved Novartis’ CAR-T tr...
by Marian Chu  |  2017-08-31 10:52
Gliatamin trademark controversy to head to Supreme Court
Daewoong Bio said Thursday it will immediately appeal to the Supreme Court ...
by Lee Han-soo  |  2017-08-31 10:00
J&J Innovation opens Seoul competition for medical innovation
Johnson & Johnson (J&J) Innovation launched its Seoul Innovation QuickFire ...
by Marian Chu  |  2017-08-31 09:13
Annual output of hypertension, hyperlipidemia drugs surpasses ₩1 tri. respectively
The manufacturing output of the antiarteriosclerotic agent, antibiotic, ant...
by Lee Hye-seon  |  2017-08-30 16:08
Diabetes, cardiovascular generics actively developed in H1
The Ministry of Food and Drug Safety said Wednesday it has approved 70 case...
by Marian Chu  |  2017-08-30 14:59
CJ Healthcare secures state support for new drug to treat rheumatoid arthritis
CJ Healthcare said Wednesday it has secured the government’s support to dev...
by Lee Han-soo  |  2017-08-30 14:20
Terminally-ill patients protest HIRA’s latest ban on off-label prescriptions on immune checkpoint inhibitors
“Withdraw your decision to ban off-label prescriptions on immune checkpoint...
by Yang Geum-deok  |  2017-08-30 14:07
Dong-A ST, Takeda to jointly sell hypertension pill ‘Edarbi’ in Korea
Dong-A ST and Takeda Pharmaceuticals Korea have signed an agreement to join...
by Lee Han-soo  |  2017-08-30 13:54
GSK tops clinical trial transparency
GlaxoSmithKline said it ranked No.1 out of 46 pharmaceutical companies in c...
by Marian Chu  |  2017-08-30 11:56
Cho-A Pharma awarded gold for children’s multi-vitamin drink
Cho-A Pharmaceutical's children's multi-vitamin drink Jalkton won t...
by Constance Williams  |  2017-08-30 11:28
FDA approves first treatment for Chagas disease
The U.S. Food and Drug Administration has approved benznidadzole to be used...
by Lee Han-soo  |  2017-08-30 11:19
Gilead to acquire Kite Pharma for $11.9 billion
Gilead, the developer of blockbuster hepatitis C and HIV treatments, said M...
by Marian Chu  |  2017-08-30 11:09
Healthcare benefits for immune checkpoint inhibitor Tecentrqi, unclear
Roche’s immune checkpoint inhibitor Tecentriq (Atezolizumab) might have a d...
by Park Gi-taek  |  2017-08-30 10:17
Hanmi plans to release Tefovir early October
Hanmi Pharmaceutical said Tuesday it will release Tefovir Tab (compound: te...
by Lee Hye-seon  |  2017-08-29 17:12
Hanall, Daewoong develop new drug for dry eye treatment
Hanall Biopharma and Daewoong Pharmaceutical said they filed an investigati...
by Marian Chu  |  2017-08-29 16:50
Back to Top